openRxiv
Validity of using cancer registry data for comparative effectiveness research
Preprints
Kumar, A; Guss, ZD; Courtney, PT; Nalawade, V; Sheridan, P; Sarkar, RR; Banegas, MP; Rose, BS; Xu, R; Murphy, JD
November 2, 2019
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Citation
APA
Chicago
ICMJE
MLA
NLM
Kumar, A., Guss, Z. D., Courtney, P. T., Nalawade, V., Sheridan, P., Sarkar, R. R., … Murphy, J. D. (2019). Validity of using cancer registry data for comparative effectiveness research. openRxiv. https://doi.org/10.1101/19010876
Kumar, Abhishek, Zachary D. Guss, Patrick T. Courtney, Vinit Nalawade, Paige Sheridan, Reith R. Sarkar, Matthew P. Banegas, Brent S. Rose, Ronghui Xu, and James D. Murphy. “Validity of using cancer registry data for comparative effectiveness research.” OpenRxiv, November 2, 2019. https://doi.org/10.1101/19010876.
Kumar A, Guss ZD, Courtney PT, Nalawade V, Sheridan P, Sarkar RR, et al. Validity of using cancer registry data for comparative effectiveness research. openRxiv. 2019.
Kumar, Abhishek, et al. “Validity of using cancer registry data for comparative effectiveness research.” OpenRxiv, 2 Nov. 2019. Crossref, doi:10.1101/19010876.
Kumar A, Guss ZD, Courtney PT, Nalawade V, Sheridan P, Sarkar RR, Banegas MP, Rose BS, Xu R, Murphy JD. Validity of using cancer registry data for comparative effectiveness research. openRxiv. 2019.